Featured-Reporter
-
Heart transplant links donor, recipient with different blood types
Pediatric cardiac surgeons at the Monroe Carell Jr. Children’s Hospital at Vanderbilt have performed the state’s first ABO incompatible heart transplant in a 2-month-old patient. Read MoreOct 9, 2013
-
VUMC poised to overcome health care challenges: Balser
While the national economy appears to be getting stronger, health care has entered a national recession, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the Vanderbilt University School of Medicine, told a packed audience of approximately 1,100 Vanderbilt faculty, staff and students in Langford Auditorium on Wednesday afternoon while making his annual State of the Medical Center address. Read MoreOct 3, 2013
-
Pioneers of Discovery: Computer science drives Capra’s biomedical research
Tony Capra, Ph.D., is a new assistant professor of Biomedical Informatics and investigator in the Center for Human Genetics Research at Vanderbilt. His goal is to use the tools of computer science to address problems in genetics, evolution and biomedicine. Read MoreOct 3, 2013
-
Study finds cognitive deficits common after critical illness
Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read MoreOct 3, 2013
-
Framingham Heart Study’s landmark impact examined
While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. Read MoreOct 3, 2013
-
Vaccine Research Program lands major NIH renewal
The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read MoreSep 26, 2013
-
Grant broadens graduate, postdoc training programs
Vanderbilt University Medical Center has received a five-year, $1.2 million grant from the National Institutes of Health (NIH) to develop “bold and innovative approaches to broaden graduate and postdoctoral training.” Read MoreSep 26, 2013
-
Leadership training effort looks to military, business
When Vanderbilt Bill Wilkerson Center director Roland Eavey, M.D., learned of the institution’s prioritized focus on training the next generation of leaders he went to two organizations he knew that were famous for doing that — the military and business schools. Read MoreSep 26, 2013
-
Awards honor leadership, commitment, compassion
The most recent Credo Award and Five Pillar Leader Award winners were announced Sept. 18 at the Clinical Enterprise Leadership Assembly at Langford Auditorium. Read MoreSep 26, 2013
-
Hyundai award helps drive hope for cancer research
Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer. Read MoreSep 19, 2013
-
Study tracks clot removal’s effectiveness at treating stroke
Over the past decade, neurointerventionalists have refined techniques for manually removing blood clots causing stroke. Now they are joining forces for a clinical trial to demonstrate the safety and effectiveness of the techniques. Read MoreSep 19, 2013
-
Transporter linked to autism risk
Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD). Read MoreSep 19, 2013
-
Researchers identify novel biomarker for diabetes risk
Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease. Read MoreSep 17, 2013
-
Embolism not about to change young singer’s tune
As a member of the Tune Town Show Chorus, 20-year-old Kyla Hallums was used to belting out songs and thought it strange when she became short of breath on Sept. 1. Read MoreSep 12, 2013
-
Options to treat childhood C. diff. infection studied
After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections. Read MoreSep 12, 2013
-
MRI used as new tool in predicting lymphedema risk
A new Vanderbilt study is the first to use magnetic resonance imaging (MRI) to noninvasively measure lymphatic flow. Read MoreSep 12, 2013
-
Program takes new approach to pain management
Patients with chronic pain who are covered by the Vanderbilt Employee Health Care Plan or workers’ compensation system can now enroll in an innovative rehabilitation program that could dramatically change how chronic pain is treated. Read MoreSep 12, 2013
-
Travis family’s Vanderbilt legacy grows
Hilliard and Nancy Travis He was a successful, self-made businessman, and she was a pioneering nurse, but the many professional accomplishments of Nancy and Hilliard Travis were eclipsed only by their ongoing generosity to the community, especially their beloved Vanderbilt. The most recent example is a generous… Read MoreSep 5, 2013
-
‘Simple Beginnings’ ceremony welcomes 98 doctoral students
Alexander Sevy dons his white coat with the help of Kathleen Gould, Ph.D., at the fourth annual “Simple Beginnings” ceremony for new doctoral students. (Photo by Anne Rayner) Vanderbilt University welcomed 98 new doctoral students into its scientific community last week during the fourth annual “Simple Beginnings”… Read MoreSep 5, 2013
-
Controversial info release aids VUMC bird flu research
Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read MoreSep 5, 2013